Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity
Research output: Contribution to journal › Conference abstract in journal › Research
| Original language | English |
|---|---|
| Article number | 177 |
| Journal | Diabetologia |
| Volume | 64 |
| Issue number | SUPPL 1 |
| Pages (from-to) | 94-94 |
| ISSN | 0012-186X |
| DOIs | |
| Publication status | Published - 2021 |
ID: 286506992